{
  "count": 1,
  "data": [
    {
      "id": "benevolentai",
      "name": "BenevolentAI",
      "short": "BenevolentAI",
      "category": "biotech",
      "founded": 2013,
      "employees": "~69",
      "funding": "$700M+",
      "funding_num_m": 700,
      "valuation": "€1.5B peak",
      "focus": "AI drug discovery",
      "ethos": "Cure disease",
      "hq": "Fitzrovia",
      "key_people": "Mulvany (Chair)",
      "milestones": "COVID baricitinib · delisted '25",
      "founders": "Mulvany",
      "careers_url": "https://www.benevolent.com/careers",
      "created_at": "2026-03-09T14:52:03.696993+00:00",
      "updated_at": "2026-03-09T14:52:03.696993+00:00",
      "ch_number": "09781806",
      "github_org": null,
      "website_url": "https://benevolent.ai",
      "twitter": "@benevolentai",
      "linkedin_url": "https://linkedin.com/company/benevolentai",
      "logo_url": "https://logo.clearbit.com/benevolent.ai",
      "tags": [
        "biotech",
        "drug-discovery",
        "public"
      ],
      "description": "BenevolentAI. AI drug discovery. Cure disease. HQ: Fitzrovia. Founded: 2013. Funding: $700M+. Tags: biotech, drug-discovery, public",
      "clients": "Pharma partners (AstraZeneca), internal drug pipeline"
    }
  ]
}